Reducing the risk of coronary events: Evidence from the Scandinavian Simvastatin survival study (4S)
- 1 September 1995
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 76 (9) , 64C-68C
- https://doi.org/10.1016/s0002-9149(99)80473-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Misleading meta-analysisBMJ, 1995
- Cholesterol lowering does have a role in secondary prevention.Heart, 1995
- The oxidation hypothesis of atherosclerosisThe Lancet, 1994
- Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatinThe Lancet, 1994
- By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?BMJ, 1994
- Should there be a moratorium on the use of cholesterol lowering drugs?BMJ, 1992
- Doubts about preventing coronary heart disease.BMJ, 1992
- Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)The American Journal of Cardiology, 1991
- The Value of Lowering Cholesterol after Myocardial InfarctionNew England Journal of Medicine, 1990
- Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.BMJ, 1990